Transient Receptor Potential Cation Channels and Calcium Dyshomeostasis in a Mouse Model Relevant to Malignant Hyperthermia
- 1 August 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Anesthesiology
- Vol. 133 (2), 364-376
- https://doi.org/10.1097/aln.0000000000003387
Abstract
Background: Until recently, the mechanism for the malignant hyperthermia crisis has been attributed solely to sustained massive Ca2+ release from the sarcoplasmic reticulum on exposure to triggering agents. This study tested the hypothesis that transient receptor potential cation (TRPC) channels are important contributors to the Ca2+ dyshomeostasis in a mouse model relevant to malignant hyperthermia. Methods: This study examined the mechanisms responsible for Ca2+ dyshomeostasis in RYR1-p.G2435R mouse muscles and muscle cells using calcium and sodium ion selective microelectrodes, manganese quench of Fura2 fluorescence, and Western blots. Results: RYR1-p.G2435R mouse muscle cells have chronically elevated intracellular resting calcium and sodium and rate of manganese quench (homozygous greater than heterozygous) compared with wild-type muscles. After exposure to 1-oleoyl-2-acetyl-sn-glycerol, a TRPC3/6 activator, increases in intracellular resting calcium/sodium were significantly greater in RYR1-p.G2435R muscles (from 153 ± 11 nM/10 ± 0.5 mM to 304 ± 45 nM/14.2 ± 0.7 mM in heterozygotes P < 0.001] and from 251 ± 25 nM/13.9 ± 0.5 mM to 534 ± 64 nM/20.9 ± 1.5 mM in homozygotes [P < 0.001] compared with 123 ± 3 nM/8 ± 0.1 mM to 196 ± 27 nM/9.4 ± 0.7 mM in wild type). These increases were inhibited both by simply removing extracellular Ca2+ and by exposure to either a nonspecific (gadolinium) or a newly available, more specific pharmacologic agent (SAR7334) to block TRPC6- and TRPC3-mediated cation influx into cells. Furthermore, local pretreatment with SAR7334 partially decreased the elevation of intracellular resting calcium that is seen in RYR1-p.G2435R muscles during exposure to halothane. Western blot analysis showed that expression of TRPC3 and TRPC6 were significantly increased in RYR1-p.G2435R muscles in a gene–dose–dependent manner, supporting their being a primary molecular basis for increased sarcolemmal cation influx. Conclusions: Muscle cells in knock-in mice expressing the RYR1-p.G2435R mutation are hypersensitive to TRPC3/6 activators. This hypersensitivity can be negated with pharmacologic agents that block TRPC3/6 activity. This reinforces the working hypothesis that transient receptor potential cation channels play a critical role in causing intracellular calcium and sodium overload in malignant hyperthermia–susceptible muscle, both at rest and during the malignant hyperthermia crisis. Editor’s Perspective: What We Already Know about This Topic: The type 1 ryanodine receptor gene (RYR1) encoding the skeletal muscle sarcoplasmic reticulum Ca2+ release channel is the primary locus for malignant hyperthermia Muscle expressing malignant hyperthermia-RYR1 mutations has chronically elevated intracellular resting calcium and sodium concentrations that increase several-fold on exposure to halothane or isoflurane What This Article Tells Us That Is New: The hypothesis that transient receptor potential cation channels play a critical role in causing intracellular calcium and sodium overload in malignant hyperthermia susceptible muscle was tested in a RYR1-p.G2435R knock-in murine model of malignant hyperthermia Skeletal muscle of mice expressing RYR1-p.G2435R had a significantly enhanced, extracellular Ca2+-dependent response to TRPC3/6 channel activators The TRPC3/6 channel activator response could be prevented by TRPC3/6 channel blockers Local administration of TRPC channel blockers during an active malignant hyperthermia crisis demonstrated that most of the rise in intracellular resting calcium in skeletal muscle comes from the extracellular space and not sarcoplasmic reticulum storesKeywords
This publication has 33 references indexed in Scilit:
- Malignant hyperthermia susceptibility arising from altered resting coupling between the skeletal muscle L-type Ca 2+ channel and the type 1 ryanodine receptorProceedings of the National Academy of Sciences of the United States of America, 2012
- Mice expressing T4826I‐RYR1 are viable but exhibit sex‐ and genotype‐dependent susceptibility to malignant hyperthermia and muscle damageThe FASEB Journal, 2011
- Identical de novo Mutation in the Type 1 Ryanodine Receptor Gene Associated with Fatal, Stress-induced Malignant Hyperthermia in Two Unrelated FamiliesAnesthesiology, 2011
- Functional and Biochemical Properties of Ryanodine Receptor Type 1 Channels from Heterozygous R163C Malignant Hyperthermia-Susceptible MiceMolecular Pharmacology, 2010
- The cell boundary theorem: a simple law of the control of cytosolic calcium concentrationThe Journal of Physiological Sciences, 2009
- The Myotonias and Susceptibility to Malignant HyperthermiaAnesthesia & Analgesia, 2009
- Diacylglycerol analogues activate second messenger‐operated calcium channels exhibiting TRPC‐like properties in cortical neuronsJournal of Neurochemistry, 2008
- Na+ entry via TRPC6 causes Ca2+ entry via NCX reversal in ATP stimulated smooth muscle cellsBiochemical and Biophysical Research Communications, 2007
- Mutations inRYR1in malignant hyperthermia and central core diseaseHuman Mutation, 2006
- Heat‐ and anesthesia‐induced malignant hyperthermia in an RyR1 knock‐in mouseThe FASEB Journal, 2005